HemOnc Today New York

The latest news from the annual meeting, including video perspective from faculty members and attendees.


Meeting News Coverage

Speaker emphasizes public awareness in Surgeon General's call to prevent skin cancer

April 13, 2015
NEW YORK — Working with the public to create behavioral change with the goal of decreasing the number of melanomas in the United States was the…
Meeting News Coverage

Identification of immunotherapy biomarkers may prove 'very difficult'

April 13, 2015
NEW YORK — Although biomarkers will be helpful to determine which patients with melanoma will have the greatest benefit and least toxicity from…
Meeting News Coverage

Merkel polyomavirus provides insights into Merkel cell carcinoma

April 11, 2015
NEW YORK — The discovery of the Merkel polyomavirus has led to improved disease tracking and management for patients with Merkel cell…
Meeting News Coverage

Plasmid IL-12 electroporation shows promise in melanoma

April 11, 2015
NEW YORK — Intratumoral plasmid interleukin-12 electroporation was associated with local necrosis and increased tumor infiltrating lymphocytes…
Meeting News Coverage

Adjuvant ipilimumab prolongs RFS in stage III melanoma

April 11, 2015
NEW YORK — Patients with high-risk stage III melanoma who received ipilimumab after complete resection demonstrated prolonged RFS compared with…
Meeting News Coverage

Phase 3 trial to compare PV-10 with chemotherapy in stage III melanoma

April 10, 2015
NEW YORK — Recruitment will begin soon for a phase 3 trial that will compare intralesional PV-10 with chemotherapy in patients with stage IIIb…
Meeting News CoveragePerspective

SLNB in pure desmoplastic melanoma remains controversial

April 10, 2015
NEW YORK — Medically fit patients with mixed desmoplastic melanoma should be offered sentinel lymph node biopsy, according to a presenter at…
Meeting News Coverage

MSLT-I results should impact future clinical trial design in melanoma

April 10, 2015
NEW YORK — Results from the Multicenter Selective Lymphadenectomy Trial-I, or MSLT-I, should influence eligibility criteria and patient…
Meeting News Coverage

Balance between benefits, harms key to limiting overdiagnosis in melanoma screening

April 10, 2015
NEW YORK — Although overdiagnosis is common in cancer screening, it is not excessive if the benefits outweigh the harms, according to a…

HemOnc Today Melanoma and Cutaneous Malignancies to highlight advances in detection, patient care

April 8, 2015
The staff of HemOnc Today and Healio.com/HemOnc will present live coverage from HemOnc Today Melanoma and Cutaneous Malignancies, scheduled for…